Biosensors & POCT– category –
-
Biosensors & POCT
Advances and Challenges in Wearable Sensors for Health Monitoring: Applications of Tear Glucose Contact Lenses and Core Body Temperature T-Sensors
ACS Publications (Review Article) International Overview This review article explores the latest advancements and challenges in wearable sensors for health monitoring. It highlights the development and application of wireless soft smart ... -
Biosensors & POCT
Nanoparticle-Based Biosensors for Shigella Monitoring in Food Safety: Advances in High-Sensitivity and Rapid Detection Highlighted in Key Review
MDPI (Review Article) International Overview This review article outlines advancements in nanoparticle-based biosensors for rapid and highly sensitive detection of foodborne pathogen Shigella spp. It comprehensively discusses various det... -
Biosensors & POCT
Self-Powered Sensor Technology for Environmental Monitoring Revolutionized: Simultaneous Nanomolar Detection of pH, Heavy Metals, and Microplastics Achieved
PMC - NIH (Review Article) International Overview This review article highlights advancements in self-powered sensors for continuous real-time monitoring of pollutants and bacteria in water, soil, and air. It presents innovative solution... -
Biosensors & POCT
Wearable Multi-Analyte Biosensors Revolutionize Diabetes Monitoring and Personalized Medicine: A Comprehensive Review of Nanostructured Electrodes and Flexible Substrate Engineering
PMC (Review Article) International Overview This review article details the path to commercializing minimally and non-invasive glucose monitoring, alongside advances in non-invasive real-time analysis of sweat, saliva, tears, and interst... -
Biosensors & POCT
iRhythm Acquires VitalConnect for $287.5 Million, Expanding Wearable Multi-Parameter Cardiac Monitoring Platform
G-MedTech America Overview iRhythm has entered a definitive agreement to acquire VitalConnect, a leader in wearable biosensor technology and ambulatory cardiac monitoring, for approximately $287.5 million. VitalConnect's FDA-cleared plat... -
Biosensors & POCT
CUREator+ Funds Six Australian Healthtech Startups with $13.5 Million to Accelerate AI Diagnostics and Digital Health Tool Development
Biotech Dispatch Australia Overview CUREator+ has provided a total of $13.5 million in funding to six Australian healthtech startups through its second funding round. This capital aims to accelerate the development and commercialization ... -
Biosensors & POCT
UT Dallas, MIT, and Tufts Universities Unveil Groundbreaking Sensor Technologies for Food Safety, Cancer/HIV Diagnostics, and Real-time Intake Monitoring
UT Dallas (via Facebook) America Overview UT Dallas developed the WaveFlex sensor utilizing nanomaterials like CeO2-NRs for Shigella detection in food. MIT researchers introduced a 50-cent CRISPR-based disposable DNA sensor for detecting... -
Biosensors & POCT
Abbott Secures CE Mark for Libre Duo Glucose-Ketone Sensor, Accelerates European Rollout of Consumer Lingo Biosensor
FreeStyle Libre Summer 2026 update Europe Overview Abbott obtained the European CE Mark in May 2026 for Libre Duo and Libre Duo 10 Day, capable of measuring both glucose and ketones for 15 days, with European market launch planned within... -
Biosensors & POCT
Non-Invasive Optical Glucose Sensing Advances with In Vivo Raman Platform Validation for Real-World Reliability: 2026 Research Unveiled
Sweet Light Global Overview Despite extensive research and investment, non-invasive optical glucose monitoring lacks FDA-approved products, but a 2026 study validated an in vivo Raman platform in oral glucose tolerance tests, marking sig... -
Biosensors & POCT
Abbott and Google Health Announce Multi-Year Partnership to Revolutionize Personal Metabolic Health Management with AI-Powered Glucose Insights
PR Newswire USA Overview Abbott and Google Health have announced a multi-year partnership to integrate glucose insights from Abbott's Lingo biowearables with Google's AI and consumer technology, aiming to make personalized metabolic heal...